Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells?
暂无分享,去创建一个
[1] L. Nicholson,et al. Cancer stem cells: problems for therapy? , 2011, The Journal of pathology.
[2] S. Morrison,et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. , 2010, Cancer cell.
[3] Chi-Hung Huang,et al. Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition , 2010, Nature Cell Biology.
[4] S. Gabriel,et al. Advances in understanding cancer genomes through second-generation sequencing , 2010, Nature Reviews Genetics.
[5] J. Settleman,et al. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.
[6] A. Murray,et al. Seeing Mutations in Living Cells , 2010, Current Biology.
[7] O. Heidenreich,et al. Understanding the cancer stem cell , 2010, British Journal of Cancer.
[8] C. Jamieson,et al. Molecular pathways to CML stem cells , 2010, International journal of hematology.
[9] A. Krešo,et al. Cancer Stem Cells and Self-renewal , 2010, Clinical Cancer Research.
[10] Alexander Roesch,et al. A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth , 2010, Cell.
[11] Ben S. Wittner,et al. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.
[12] Hans Clevers,et al. Coexistence of Quiescent and Active Adult Stem Cells in Mammals , 2010, Science.
[13] P. Pelicci,et al. Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content , 2010, Cell.
[14] R. Huang,et al. Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.
[15] Julia Schüler,et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.
[16] S. Morrison,et al. Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.
[17] Michael F. Clarke,et al. Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.
[18] Eric S. Lander,et al. Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.
[19] M. Nieto,et al. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. , 2009, The Journal of clinical investigation.
[20] M. Diehn,et al. Therapeutic implications of the cancer stem cell hypothesis. , 2009, Seminars in radiation oncology.
[21] K. Polyak,et al. Cancer stem cells: a model in the making. , 2009, Current opinion in genetics & development.
[22] Tannishtha Reya,et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia , 2009, Nature.
[23] A. Puisieux,et al. Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.
[24] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[25] A. Menke,et al. Microenvironmental regulation of E-cadherin-mediated adherens junctions. , 2008, Frontiers in bioscience : a journal and virtual library.
[26] Mark Shackleton,et al. Efficient tumour formation by single human melanoma cells , 2008 .
[27] J. Dick,et al. Comment on "Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells" , 2007, Science.
[28] H. Clevers,et al. Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.
[29] C. Heeschen,et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.
[30] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[31] L. Ricci-Vitiani,et al. Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.
[32] Thomas Kirchner,et al. Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.
[33] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[34] Keisuke Ito,et al. Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche , 2004, Cell.
[35] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] T. Brabletz,et al. Tumor patterning: analogies of neoplastic morphogenesis with embryogenesis. , 2000, Verhandlungen der Deutschen Gesellschaft fur Pathologie.
[37] J. Drake,et al. Rates of spontaneous mutation. , 1998, Genetics.
[38] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.
[39] Kathleen R. Cho,et al. Genetic alterations in the adenoma–carcinoma sequence , 1992, Cancer.
[40] T. Sun,et al. Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis , 1990, Cell.
[41] L. Loeb,et al. Errors in DNA synthesis: a source of spontaneous mutations. , 1990, Mutation research.
[42] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.